Skills and Pills for Depression: What Works and What Hurts, and How to Talk About It
–
October 4, 2025
Saturday, October 4, 2025 1:00pm - 5:30pm
Grand Ballroom, Joe Crowley Student Union
University of Nevada Reno
1664 N. Virginia Street, Reno NV 89557
4 CE Credits for Mental Health Professionals (includes 1 Suicide and 2 Ethics CE credit)
4 CMEs for Medical Professionals (includes 1 Suicide CME and 2 Ethics CMEs)***
CE Approvals:
This program is approved for NV Psychologists directly by the Nevada Board of Psychological Examiners and also directly by the Board of Examiners for MFTs and LCSWs. It is approved for 4 CE credits, which includes 1 Suicide CE and 2 Ethics CE credits.
***This program is also approved directly by the Nevada Board of Medical Examiners. This program provides 4 CMEs, including 1 CME credit towards the Nevada State Board of Medical Examiners' requirement for 2 hours of training related to suicide prevention, intervention and detection every 4 year and 2 hours of training related to Ethics. See below under General Information-CE Approvals for additional details.
Please note: The Nevada Psychological Association is co-sponsoring this event and will be issuing CE certificates to Nevada Psychologists, LCSWs, MFTs and Medical Professionals that wish to receive the 4 CE credits/4 CMEs that have been directly approved by state licensing Boards. NPA does not maintain responsibility for this program or its content as an APA-approved provider of continuing education.
About the Workshop:
The goal of this conference is to engage professionals, both prescribers and non-prescribers, members of the public, and introductory psychology students in a discussion of the scientific evidence regarding how medications compare with nondrug treatments for depression, and how patients can effectively collaborate with their doctors about their choices when seeking treatment for depression, in order to maximize benefit and minimize risk.
Learning Objectives:
At the end of this workshop, attendees will be able to:
1) Understand the differences between the FDA and FAA (Federal Aviation Authority) and the implications for them.
2) Learn at least 2 key details about the history of antidepressants and RCTs.
3) Cite the landmark NEJM study (Turner et al., 2008) and specify what percentage of antidepressant trials were judged to be positive as analyzed by the FDA.
4) Know how many positive trials the FDA requires in order to approve a new medication for a specific use.
5) Articulate what led the FDA to impose a Black Box Warning that antidepressants can cause suicidal behavior.
6) Identify and address at least one specific physiological antidepressant side effect that is thought to be connected to suicidal behavior.
7) Cite at least 2 studies comparing psychological interventions with antidepressants.
8) Specify at least 2 scientifically supported specific psychological interventions for depression.
9) Ask 2 specific questions of their doctor to help appropriately guide their treatment choices.
10) Walk away with a copy of a model informed consent template they can modify for their own use.
11) Devise at least 2 ways to intervene effectively when treatment goes wrong.
Audience:
This workshop is intended for the entire community, both professionals and nonprofessionals. Though it will be presented at an intermediate level, it will be delivered in language that the average consumer can digest. It will likely be new information for many mental health professionals because many mental health graduate programs do not cover this information adequately.